Advanced search
1 file | 4.90 MB

PARP-inhibitors in breast and ovarian cancer

VIBEKE KRUSE (UGent) , Veronique Cocquyt (UGent) , Rudy Van den Broecke (UGent) , Geert Braems (UGent) and Hannelore Denys (UGent)
Author
Organization
Keywords
PARP inhibitors, DNA repair, synthetic lethality, chemopotentiation, targeted therapy, BRCA1/2 mutations, BRCAness

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 4.90 MB

Citation

Please use this url to cite or link to this publication:

Chicago
KRUSE, VIBEKE, Veronique Cocquyt, Rudy Van den Broecke, Geert Braems, and Hannelore Denys. 2011. “PARP-inhibitors in Breast and Ovarian Cancer.” Belgian Journal of Medical Oncology 5 (2): 62–69.
APA
KRUSE, V., Cocquyt, V., Van den Broecke, R., Braems, G., & Denys, H. (2011). PARP-inhibitors in breast and ovarian cancer. BELGIAN JOURNAL OF MEDICAL ONCOLOGY, 5(2), 62–69.
Vancouver
1.
KRUSE V, Cocquyt V, Van den Broecke R, Braems G, Denys H. PARP-inhibitors in breast and ovarian cancer. BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 2011;5(2):62–9.
MLA
KRUSE, VIBEKE, Veronique Cocquyt, Rudy Van den Broecke, et al. “PARP-inhibitors in Breast and Ovarian Cancer.” BELGIAN JOURNAL OF MEDICAL ONCOLOGY 5.2 (2011): 62–69. Print.
@article{1987404,
  author       = {KRUSE, VIBEKE and Cocquyt, Veronique and Van den Broecke, Rudy and Braems, Geert and Denys, Hannelore},
  issn         = {1784-7141},
  journal      = {BELGIAN JOURNAL OF MEDICAL ONCOLOGY},
  keyword      = {PARP inhibitors,DNA repair,synthetic lethality,chemopotentiation,targeted therapy,BRCA1/2 mutations,BRCAness},
  language     = {eng},
  number       = {2},
  pages        = {62--69},
  title        = {PARP-inhibitors in breast and ovarian cancer},
  volume       = {5},
  year         = {2011},
}